Agios Pharmaceuticals

Ebitda változás Dátum
AbbVie USD 4.49B 2.26B 2024-03
Alnylam Pharmaceuticals USD -2848000 100.07M 2024-03
Amgen USD 2.16B 1.5B 2024-03
Arrowhead Research USD -115227000 17.06M 2024-03
Astellas Pharma JPY 66.37B 30.25B 2023-12
AstraZeneca USD 3.43B 412M 2023-09
Bayer EUR 4.35B 1.29B 2024-03
Biogen USD 681.5M 29.4M 2024-03
BioMarin Pharmaceutical USD 136.44M 81.36M 2024-03
Bristol-Myers Squibb USD -8559000000 13.45B 2024-03
Daiichi Sankyo JPY 114.45B 49.03B 2023-12
Eli Lilly USD 3.12B 720.2M 2024-03
Exelixis USD 68.68M 79.96M 2024-03
Gilead Sciences USD -3542000000 6.27B 2024-03
GlaxoSmithKline GBP 2.07B 317M 2024-03
Incyte USD 258.54M 31.54M 2024-03
Ionis Pharmaceuticals USD -116518000 113.59M 2024-03
Merck USD 6.96B 557M 2024-03
Moderna USD -1123000000 1.33B 2024-03
Pfizer USD 5.95B 4.81B 2024-03
Regeneron Pharmaceuticals USD 830.9M 485.5M 2024-03
Roche Holding CHF 12.35B 1.92B 2023-06
Sarepta Therapeutics USD 54.36M 64.27M 2024-03
Vertex Pharmaceuticals USD 1.34B 262.8M 2024-03



Agios Pharmaceuticals - Az oldal aktuális és múlbeli adatokat, elorejelzéseket, statisztikákat, grafikonokat és a gazdasági naptár adatait tartalmazza - Jun 2024.